An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
Top results in this bookTable of Contents
Nivolumab and Relatlimab (Opdualag): CADTH Reimbursement Recommendation: Indication: For the treatment of adult and pediatric patients 12 years of age or older with unresectable or metastatic melanoma who have not received prior systemic therapy for unresectable or metastatic melanoma [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Feb.
DNA Mismatch Repair Deficiency Tumour Testing for Patients With Colorectal Cancer: Recommendations [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Aug. (CADTH Optimal Use Report, No. 5.3d.)
Melanoma: assessment and management.
London: National Institute for Health and Care Excellence (NICE); 2022 Jul 27. (NICE Guideline, No. 14.)
Trifluridine-Tipiracil (Lonsurf): CADTH Reimbursement Recommendation: Indication: In combination with bevacizumab, for the treatment of adult patients with metastatic colorectal cancer who have previously been treated with, or are not candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-VEGF biological agents, and, if RAS wild-type, anti-EGFR agents [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Mar.
Colorectal cancer.
London: National Institute for Health and Care Excellence (NICE); 2021 Dec 15. (NICE Guideline, No. 151.)
Selpercatinib (Retevmo): CADTH Reimbursement Recommendation: Indication: Adult patients with rearranged during transfection (RET) fusion-positive differentiated thyroid carcinoma with advanced or metastatic disease (not amenable to surgery or radioactive iodine therapy) following prior treatment with sorafenib and/or lenvatinib [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jul.
Lung cancer: diagnosis and management.
London: National Institute for Health and Care Excellence (NICE); 2024 Mar 8. (NICE Guideline, No. 122.)
Brain tumours (primary) and brain metastases in adults.
London: National Institute for Health and Care Excellence (NICE); 2021 Jan 29. (NICE Guideline, No. 99.)
Tepotinib (Tepmetko): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with locally advanced unresectable metastatic non–small cell lung cancer (NSCLC) harbouring mesenchymal-epithelial transition (MET) tyrosine kinase receptor exon 14 skipping alterations [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Sep.
Pembrolizumab (Keytruda): CADTH Reimbursement Recommendation: Indication: Adjuvant treatment of adult and pediatric (12 years and older) patients with stage IIB or IIC melanoma following complete resection [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Nov.
Screening for Ovarian Cancer: An Updated Evidence Review for the U.S. Preventive Services Task Force [Internet].
Henderson JT, Webber EM, Sawaya GF.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Feb. (Evidence Synthesis, No. 157.)
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on